Forbes July 1, 2024
Kanvas Biosciences aims to create a “Google Maps” for the microbiome that can help fine-tune treatments for cancer and other diseases.
Over the past two decades, immunotherapies have become a key tool in doctors’ arsenals for cancer patients. This class of drug uses the body’s own immune system to attack tumors. But despite their growing utilization, checkpoint inhibitors — a type of immunotherapy — are unsuccessful in many cancer patients.
In some cases, this lack of response has to do with a patient’s microbiome — the community of bacteria and other microorganisms that live in the gut. For these patients, doctors are experimenting with fecal microbiota transplants — a way to transfer a healthy person’s microbial ecosystem into another person....
Today's Sponsors
Today's Sponsor